


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31200034</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>06</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1615-5947</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jun</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of vascular surgery</Title>
                <ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cryopreserved Allografts for treatment of Chronic Limb-threatening Ischemia in patients without Autologous Saphenous Veins.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0890-5096(19)30372-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2019.03.018</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Revascularization is the best alternative to reduce symptoms and to improve the limb salvage rate in patients with Chronic Limb-threatening Ischemia (CLI). Alternative grafts as synthetic prostheses and allografts must be considered for patients without a suitable autologous graft (SAG). Our aim is to evaluate outcomes of cryopreserved allografts used as a vascular conduit for bypass surgery in the infra-inguinal territory.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective analysis (January 1995 to January 2014) of the Registry of vascular and valvular allografts transplant in the autonomous community of Catalonia, Spain (ReVAC) was performed for identifying patients with CLI who required infra-inguinal bypass with cryopreserved arterial allografts. Statistical analysis was performed using SPSS Ver. 20 for Mac (Chicago, USA).</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 149 patients with CLI (mean age of 70.1 years) were analyzed. 102 patients (68.5%) had a grade IV lesion (Fontaine classification). In the overall follow-up, 24.8% of patients required a reintervention. Overall graft occlusion, infection and dilation rate were 52.3%, 6% and 5.4% respectively. Overall 30-days mortality was 0.7%. 5-year primary patency rate and limb salvage rate were 38.6% and 50.2% respectively. Survival rate at 5 years was 54.2%. Major Adverse Limb Event (MALE)-free rate was 21.5% at 5 years. Revascularization to a distal target vessel was an independent positive predictive risk factor for a lower limb salvage rate and lower primary patency rate. Dyslipemia was related to a lower limb salvage rate and represents a risk factor involved in major adverse limb events.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Arterial allografts seem to represent a suboptimal alternative although some selected patients could beneficiate of them. 5-year results are disappointing and more studies are required to know other predictor factors for a better selection of patients.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Guevara-Noriega</LastName>
                    <ForeName>K A</ForeName>
                    <Initials>KA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research and Clinical Staff at Vascular Surgery Department. Centro Médico Teknon. Barcelona, Spain; Vascular Surgery Staff. Consorci Sanitari Parc Tauli, Sabadell, Spain. Electronic address: kerbiguevara@hotmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gustavo Adolfo</LastName>
                    <ForeName>Lucar-Lopez</ForeName>
                    <Initials>LL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Orthopedic Surgery. Hospital of Mataro, Maresme, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jose Luis</LastName>
                    <ForeName>Pomar</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cardiovascular Surgery Department. Hospital Clinic i Provincial, Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Ann Vasc Surg</MedlineTA>
            <NlmUniqueID>8703941</NlmUniqueID>
            <ISSNLinking>0890-5096</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Chronic Limb-threatening Ischemia</Keyword>
            <Keyword MajorTopicYN="N">Cryopreserved Allografts</Keyword>
            <Keyword MajorTopicYN="N">MALE</Keyword>
            <Keyword MajorTopicYN="N">Vascular Tissue</Keyword>
            <Keyword MajorTopicYN="N">Vascular Transplant</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31200034</ArticleId>
            <ArticleId IdType="pii">S0890-5096(19)30372-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.avsg.2019.03.018</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

